Sentinus LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-537
Closed -$209K 239
2025
Q2
$209K Sell
537
-22
-4% -$8.85K 0.05% 206
2025
Q1
$243K Buy
+559
New +$224K 0.07% 175
2024
Q4
Sell
-399
Closed -$207K 186
2024
Q3
$207K Hold
399
0.06% 179
2024
Q2
$216K Buy
+399
New +$211K 0.07% 170

Other funds holding ELV

Sentinus LLC's ELV Position: Q3 2025 in Review

Sentinus LLC sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 537 shares — an estimated $209K sold.

Sentinus LLC first reported a position in ELV in Q2 2024 and held it in 4 quarters. The position peaked at $243K in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Sentinus LLC reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Sentinus LLC sold 537 Elevance Health shares in Q3 2025, an estimated $209K.
  • Sentinus LLC first reported a position in Elevance Health in Q2 2024 and held it in 4 quarters.
  • Sentinus LLC's Elevance Health position peaked at $243K in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Sentinus LLC's 13F filing for Q3 2025, filed 14 Nov 2025.